Core Points - Universal Health Services, Inc. (UHS) is scheduled to have presentations at multiple healthcare conferences in March 2025 [1][2] - The company operates a wide range of healthcare facilities, including acute care hospitals and behavioral health facilities, across the United States, Puerto Rico, and the United Kingdom [3] Conference Details - Steve Filton, Executive Vice President and CFO, will present at the TD Cowen 45th Annual Health Care Conference on March 3, 2025, at 9:10 am (ET) in Boston, MA [1] - Following that, he will present at the Leerink Partners 2025 Global Healthcare Conference on March 10, 2025, at 1:00 pm (ET) in Miami Beach, FL [1] - Additionally, there will be a presentation at the Barclays 27th Annual Global Healthcare Conference on March 11, 2025, at 8:50 am (ET) in Miami Beach, FL [2] Company Overview - UHS is one of the largest providers of hospital and healthcare services in the nation [3] - The company operates various types of facilities, including outpatient and ambulatory care access points [3]

Facilities and Operations - As of September 30, 2024, the company owned and/or operated 361 inpatient facilities and 49 outpatient facilities across 39 states, Washington, D.C., the U.K., and Puerto Rico[68]. - Average daily census for acute care facilities increased to 4,277.4 for the three-month period ended September 30, 2024, compared to 4,177.7 for the same period in 2023[85]. - Average daily census for behavioral health care services was 17,590.7 for the three months ended September 30, 2024, compared to 17,240.3 in the same period of 2023[97]. - Total admissions for acute care facilities increased to 81,731 for the three-month period ended September 30, 2024, compared to 80,074 for the same period in 2023[85]. - The occupancy rate for the facilities was 73% for the nine-month period ended September 30, 2024, compared to 72% in the prior year[101]. Financial Performance - Net revenues increased by 11.2%, or $400 million, to $3.963 billion for the three-month period ended September 30, 2024, compared to $3.563 billion in the same period of 2023[80]. - Income before income taxes increased by $121 million, or 55%, to $342 million during the three-month period ended September 30, 2024, compared to $221 million in the third quarter of 2023[80]. - Net income attributable to UHS increased by $92 million, or 55%, to $259 million during the three-month period ended September 30, 2024, compared to $167 million in the same period of 2023[80]. - Net revenues for the nine months ended September 30, 2024, are $9,384,032 thousand, compared to $11,454,260 thousand for the twelve months ended December 31, 2023, indicating a decline[180]. - Net income for the nine months ended September 30, 2024, is $689,397 thousand, an increase from $556,423 thousand for the twelve months ended December 31, 2023[180]. Revenue Sources - Net revenues from acute care hospitals and outpatient facilities accounted for 57% of consolidated net revenues for the three-month periods ended September 30, 2024 and 2023[69]. - Behavioral health care facilities in the U.K. generated net revenues of approximately $230 million for the three-month period ended September 30, 2024, compared to $203 million for the same period in 2023[69]. - The company experienced a $975 million, or 9.4%, increase in net revenues from acute care hospital services and behavioral health services on a same facility basis[82]. - For the nine-month period ended September 30, 2024, net revenues from acute care hospital services increased by $610 million, or 10.2%, due to a $497 million increase in Same Facility revenues[92]. - Net revenues from behavioral health services increased by $527 million, or 11.5%, during the nine-month period ended September 30, 2024, compared to the same period in 2023[105]. Expenses and Costs - The company experienced significant increases in hospital-based physician-related expenses, particularly in emergency room care and anesthesiology, which could adversely impact future results[72]. - Salaries, wages, and benefits accounted for 48.3% of net revenues in Q3 2024, compared to 50.1% in Q3 2023[80]. - Other operating expenses increased to $1.090 billion, representing 27.5% of net revenues in Q3 2024, up from 26.4% in Q3 2023[80]. - Salaries, wages, and benefits expense increased by $39 million, or 4.6%, but as a percentage of net revenues, it decreased to 41.6% in Q3 2024 from 43.5% in Q3 2023[87]. - Other operating expenses increased by $102 million, or 17.2%, in the third quarter of 2024, attributed to a $55 million increase related to acute care hospital services and a $47 million increase in provider tax assessments[92]. Regulatory and Legislative Risks - The company faces risks related to potential changes in healthcare legislation that could impact reimbursement levels and operational costs[74]. - The Budget Control Act of 2011 has resulted in Medicare payment reductions of up to 2% per fiscal year, extended through 2032, impacting the company's financial outlook[75]. - The company is particularly sensitive to potential reductions in Medicaid and other state-based revenue programs, receiving approximately $100 million annually from multiple states[75]. - The Managed Care Rule could have a material adverse impact on the company's future results of operations if implemented as proposed[150]. - The Medicaid DSH payments are scheduled to be reduced by $8 billion annually from FFY 2025 through FFY 2027, with delays in implementation due to recent legislation[153]. Cash Flow and Financing - Net cash provided by operating activities increased by $593 million to $1.409 billion for the nine-month period ended September 30, 2024, compared to $815 million for the same period in 2023[166]. - The company spent $718 million on net cash used in financing activities during the first nine months of 2024, compared to $312 million in the same period in 2023[169]. - The company generated $2.210 billion from additional borrowings during the first nine months of 2024, including $1.200 billion from a new tranche A term loan facility[169]. - The company incurred a pre-tax charge of approximately $6 million related to the costs of extinguishing debt during the three and nine-month periods ended September 30, 2024[163]. - The company anticipates sufficient capital resources to fund its operating, investing, and financing requirements for the next twelve months[174]. Insurance and Liabilities - As of September 30, 2024, the company has approximately $221 million in aggregate insurance coverage remaining under commercial policies for matters applicable to the 2020 policy year[74]. - Total liabilities as of September 30, 2024, are $7,333,860 thousand, a slight decrease from $7,515,013 thousand on December 31, 2023[179]. - Off-balance sheet arrangements as of September 30, 2024, total $154 million, including $130 million related to self-insurance programs[183]. - The company has goodwill of $3,262 million as of September 30, 2024, compared to $3,267 million on December 31, 2023[179]. - The carrying value of the company's debt was approximately $4.7 billion as of September 30, 2024, down from $4.9 billion at December 31, 2023[174].

Momentum investors typically don't time the market or "buy low and sell high." In other words, they avoid betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time. Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potential fails to justify their swelled-up valuation. In that phas ...

Universal Health Services (UHS) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company. The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annua ...

Momentum Investing Overview - Momentum investing focuses on following a stock's recent trend, aiming to buy high and sell even higher [1] - The strategy relies on identifying stocks that are likely to continue moving in their current direction [1] Universal Health Services (UHS) Performance - UHS shares have risen 18.18% over the past week, outperforming the Zacks Medical - Hospital industry's 10.13% gain [2] - Over the past month, UHS shares have increased by 15.55%, compared to the industry's 10.43% performance [2] - UHS has seen a 27.42% rise over the past quarter and a 54.02% increase over the last year, significantly outperforming the S&P 500's 7.48% and 21.12% gains, respectively [8] Trading Volume and Momentum Indicators - UHS has an average 20-day trading volume of 816,389 shares, which is a useful indicator for establishing price-to-volume baselines [3] - A rising stock with above-average volume is generally considered a bullish sign [3] Earnings Estimate Revisions - Over the past two months, 3 earnings estimates for UHS have moved higher compared to 1 lower for the full year, boosting the consensus estimate from $13.64 to $14.19 [13] - For the next fiscal year, 3 estimates have moved upwards with no downward revisions in the same period [13] Zacks Rank and Momentum Style Score - UHS currently holds a Zacks Rank of 2 (Buy) and a Momentum Style Score of A, indicating strong potential for outperformance [6][14] - Stocks with Zacks Rank 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B tend to outperform the market over the following one-month period [6] Industry Comparison and Momentum Metrics - Comparing a stock's short-term price activity to its industry can help identify top companies in a particular sector [7] - Longer-term price metrics, such as performance over the last three months or year, are also advantageous for evaluating momentum [8]

The stock has a great record of positive earnings surprises, as it hasn't missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on July 24, 2024, Universal Health Services reported EPS of $4.31 versus consensus estimate of $3.37. Universal Health Services may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback ...

Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, investors find themselves loaded up on expensive shares with limited to no upside or even a downside. So, going all-in on momentum could be risky at times. There are several stocks that currently pass through the screen and Universal Health Services (UHS) is one of them. Here are th ...

Universal Health Services, Inc. (NYSE:UHS) Q2 2024 Earnings Conference Call July 25, 2024 9:00 AM ET Company Participants Steve Filton - Executive Vice President & Chief Financial Officer Marc Miller - President & Chief Executive Officer Conference Call Participants Ann Hynes - Mizuho Securities Stephen Baxter - Wells Fargo Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Justin Lake - Wolfe Research Jason Cassorla - Citi Sarah James - Cantor Fitzgerald Andrew Mok - Barclays Pito Chickering - Deutsche Bank ...

Share Repurchase Update Adjusted EBITDA, net of NCI, is now estimated to be in the range of $2.154-$2.226 billion. The midpoint of the guidance suggests a 25.7% improvement from the 2023 figure. UHS increased its adjusted EPS guidance in the range of $15.4-$16.2. The midpoint of the forecast indicates a rise of 49.9% from the 2023 figure. Other Medical Sector Releases HCA Healthcare reported second-quarter 2024 adjusted EPS of $5.50, which beat the Zacks Consensus Estimate by 10.7%. The bottom line improved ...

FOR IMMEDIATE RELEASE July 24, 2024 CONTACT: Steve Filton Chief Financial Officer 610-768-3300 UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES 2024 SECOND QUARTER FINANCIAL RESULTS, INCREASES 2024 FULL YEAR OPERATING RESULTS FORECAST AND ANNOUNCES $1 BILLION INCREASE TO STOCK REPURCHASE PROGRAM AUTHORIZATION Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended June 30, 2024 and 2023: KING OF PRUSSIA, PA – Universal Health Services, Inc. (NYSE: UHS) announced today that its r ...